Svenska (Sverige) Dansk (Danmark) Norsk bokmål (Norge) Estonian (Estonia) Finnish (Suomi)
GITR: Immunoregulatory receptor. IHC validated

Give your tumor immunology research a boost – new GITR antibody

GITR is an immune checkpoint target that may present a unique opportunity for immunotherapeutic intervention in cancer.
You can now explore the function of GITR with the new GITR rabbit monoclonal from Cell Signaling Technology, offering superior performance in IHC.

Learn more about immune checkpoint targets.

The picture shows IHC analysis of parraffin-embedded human lung carcinoma using #68014.


BioNordika AS ♦ Gladengveien 3 B, 0661 Oslo ♦ Tel: 23 03 58 00 ♦ Faks: 23 03 58 01 ♦ E-post: